The Week in Review: December 1 – December 8, 2017

Friday, December 8, 2017 News Recap: URGENT BC Patient and Caregiver Input Request: Vosevi. We need to hear your voice! Patient and Caregiver input is requested by BC PharmaCare on Gilead’s combo of sofosbuvir, velpatasvir, and voxilaprevir (SOF-VEL-VOX or Vosevi™) for Genotypes 1-6. Personal Stories This week we have two great stories of triumphing over HepC: Aidain’s ‘I will never forget the day I found out I had hepatitis c’, and Patric...

URGENT BC Patient and Caregiver Input Request: Vosevi

URGENT BC Patient and Caregiver Input Request: We need to hear your voice! Patient and Caregiver input is requested by BC PharmaCare on Gilead’s combo of sofosbuvir, velpatasvir, and voxilaprevir (SOF-VEL-VOX or Vosevi™) for Genotypes 1-6. Check out the background information in links below to see the results that have been achieved in clinical trials to date. Gilead’s “SOF-VEL-VOX” combo is pan-genotypic (works for all genotypes). One pill

The Week in Review: October 20 – October 27, 2017

Friday, October 27, 2017 News Recap: Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6. We need to hear your voice by November 8, 2017!  AbbVie’s “GP” combo is pan-genotypic (works for all genotypes). Liver Meeting 2017: I’m A HCV Patient – Show Me What I Need to Know! Why reinvent the wheel? The good folks over at HCV New Drugs have put together this great overview o...

Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6

URGENT BC Patient and Caregiver Input Request: We need to hear your voice! Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6.  AbbVie’s “GP” combo is pan-genotypic (works for all genotypes).  Check out the background information in links below to learn the results that have been achieved in clinical trials to date. You will see that the cure rates across all genotypes are hig

REQUEST: Patient input for BC Pharmacare RE: HOLKIRA PAK™

BC PharmaCare has issued a call for Patient Input into whether they should cover AbbVie's new hepatitis C treatment, HOLKIRA PAK™ (ombitasvir, paritaprevir, ritonavir, and dasabuvir [±ribavirin]).HepCBC is going to make a submission to BC PharmaCare, and URGENTLY requests input from those who have, or have ever had hepatitis C (and their caregivers). Our submission is only as good as the input we get from people like you!You would have to answer a few ques

SOVALDI Webinar slides – Link to Dr Ramji July 3 presentation

Link to July 3, 2014 WEBINAR about Sovaldi by Dr. Alnoor Ramji, co-hosted by HepCBC and the Pacific Hepatitis C Network. You just need to type in your name, email, etc. - no PW required. This webinar will only be online through July 14, 2014. To submit your voice to the Sovaldi (sofosbuvir) heptitis C drug review, please go to this page: http://hepcbc.ca/2014/07/sovaldi-bc/ . Sovaldi is produced by Gilead Sciences.